Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2024 14:30 ET | Source: Foundation Fighting Blindness

Foundation Fighting Blindness Partners with University of Colorado Anschutz Medical Campus and Other Leading Institutions to Secure Up to $46 Million to Fast Track Whole Eye Transplantation Program

ARPA-H award establishes multi-disciplinary consortium of industry experts to address current limitations and advance innovative technologies for vision-restoring whole eye transplantation Goal to...
January 09, 2020 14:00 ET | Source: Foundation Fighting Blindness

Foundation Fighting Blindness Celebrates 15th Year of VisionWalk with New Branding

Columbia, MD, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness launches 2020 with a bold, new logo and branding for its signature fundraising event, VisionWalk. VisionWalk...
October 02, 2019 07:00 ET | Source: Foundation Fighting Blindness

Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness launch an open access program for patients with inherited retinal disease in the United States

COLUMBIA, Maryland, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness have announced that beginning in October 2019, a new open-access program...
July 15, 2019 10:00 ET | Source: Foundation Fighting Blindness

Foundation Fighting Blindness Appoints Judy Taylor Vice President, Development

Columbia, MD, July 15, 2019 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness, the world’s leading private funding source for retinal degenerative disease research, has announced that it has...
February 12, 2018 07:00 ET | Source: ProQR Therapeutics N.V.; Foundation Fighting Blindness

Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A

Foundation Fighting Blindness and ProQR enter into a partnership to develop QR-421a for Usher syndrome type 2A, targeting mutations in exon 13 of the causative USH2A gene. Foundation Fighting...
November 13, 2017 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic Blindness

Key Updates The first patient has received the first dose of QR-110 in the Phase 1/2 safety & efficacy clinical trial (PQ-110-001: NCT03140969) in children and adults with Leber’s congenital...
August 21, 2012 17:15 ET | Source: Foundation Fighting Blindness

Foundation Fighting Blindness Announces $2.4 Million in Funding for Eight New Sight-Saving Research Projects

OWINGS MILLS, Md. and COLUMBIA, Md., Aug. 21, 2012 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness announces an investment of $2.4 million in eight promising research projects aimed at providing...
October 31, 2011 13:05 ET | Source: Foundation Fighting Blindness

Foundation Fighting Blindness Invests $8.25 Million in Six Gene Therapy Research Projects Poised for Clinical Trials

COLUMBIA, Md., Oct. 31, 2011 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness, a national nonprofit dedicated to advancing sight-saving research, announces an $8.25 million investment in six new...